Status:
COMPLETED
Influenza Vaccine in Lung Transplant Patients
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Influenza
Eligibility:
All Genders
18+ years
Brief Summary
This 5-year study was designed to investigate how antibody and T cell responses following influenza vaccine compare among lung transplant patients, patients waiting for lung transplantation, and healt...
Detailed Description
\[Note: there are 6 ClinicalTrials.gov records associated with this study, each representing a different sub-study of the population over the 5-year period, please see NCT04533061, NCT04533139, NCT045...
Eligibility Criteria
Inclusion
- Receiving care pre- or post-lung transplant at University of Wisconsin Hospital
- Healthy adult
Exclusion
- Allergy to eggs
- Moderate to severe febrile illness
- Active treatment for acute rejection
- Received season's influenza vaccine prior to enrollment
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00205270
Start Date
December 1 2004
End Date
July 1 2009
Last Update
October 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792